OP022 Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST studyStefan Schreiber, Ana P. Lacerda, Alessandro Armuzzi et al.|Journal of Crohn s and Colitis|2018Cited by 14
P533 Correlation of endoscopic and clinical endpoints during induction therapy in patients with moderate-to-severe Crohn’s disease: Analysis from CELEST studyWilliam J. Sandborn, Ana P. Lacerda, B. Feagan et al.|Journal of Crohn s and Colitis|2018Cited by 3